# US 2017/0286594 A1 · Genetic Variant-Phenotype Analysis System And Methods Of Use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0286594 A1
- Document ID: US20170286594A1
- Status: Published application
- Kind: A1
- Application number: 15/473,302
- Filed: 2017-03-29
- Published: 2017-10-05
- Earliest claimed: 2016-03-29
- Applicants: Regeneron Pharmaceuticals, Inc.
- Inventors: Jeffrey Reid; Omri Gottesman; Lukas Habegger; Brian Cajes; Jeffrey Staples; Evan Maxwell
- Web page: https://patentgrep.com/patent/US20170286594A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 20/10: Ploidy or copy number detection
- G16B 20/40: Population genetics; Linkage disequilibrium
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Methods and systems for generating and analyzing genetic variant-phenotype association results are disclosed.

## Claims

### Claim 1

A system comprising:
a genetic data component configured for functionally annotating one or more genetic variants obtained from sequence data;
a phenotypic data component configured for determining one or more phenotypes for one or more patients for whom the sequence data was obtained and analyzed by the genetic data component;
a genetic variant-phenotype association data component configured for determining one or more associations between the one or more genetic variants and the one or more phenotypes; and
a data analysis component configured for generating, storing, and indexing the one or more associations from the genetic variant-phenotype association data component.

### Claim 2 (depends on 1)

The system of claim 1, wherein the functionally annotating of the one or more genetic variants generates genetic variant data.

### Claim 3 (depends on 2)

The system of claim 2, wherein one or more variants in the genetic variant data are assessed for functional impact on transcripts/genes and potential loss-of-function (pLoF) candidates are identified.

### Claim 4 (depends on 1)

The system of claim 1, wherein the genetic data component comprises a variant identification component comprised of a trimming component, an alignment component, and a variant calling component.

### Claim 5 (depends on 1)

The system of claim 1, wherein the genetic data component comprises a variant annotation component comprised of a functional predictor component.

### Claim 6 (depends on 5)

The system of claim 5, wherein the variant annotation component is configured to determine and assign functional information to the one or more genetic variants.

### Claim 7 (depends on 5)

The system of claim 5, wherein the variant annotation component is configured to categorize each of the one or more genetic variants based on the variant's relationship to a coding sequence in a genome and how the one or more genetic variants may change the coding sequence and affect a gene product.

### Claim 8 (depends on 1)

The system of claim 1, wherein the determining the one or more phenotypes for the one or more patients for whom the sequence data was obtained and analyzed by the genetic data component generates phenotypic data.

### Claim 9 (depends on 1)

The system of claim 1, wherein the phenotypic data component comprises one or more of a binary phenotype component, a quantitative phenotype component, a categorical phenotype component, or a clinical narrative phenotype component.

### Claim 10 (depends on 9)

The system of claim 9, wherein the binary phenotype component is configured for analyzing de-identified medical information to identify one or more codes assigned to a patient in the de-identified medical information.

### Claim 11 (depends on 11)

The system of claim 11, wherein the quantitative phenotype component is configured for analyzing de-identified medical information to identify a continuous variable and assign a phenotype based on the identified continuous variable.

### Claim 12 (depends on 1)

The system of claim 1, wherein the genetic variant-phenotype association data component comprises a computational component and a quality component.

### Claim 13 (depends on 12)

The system of claim 12, wherein the computational component is configured for performing one or more statistical tests.

### Claim 14 (depends on 1)

The system of claim 1, further comprising:
a phenotype data interface coupled to the phenotypic data component;
a genetic variant data interface coupled to the genetic data component;
a pedigree interface coupled to the genetic data component; and
a results interface coupled to the phenotypic data component and the data analysis component.

### Claim 15 (depends on 14)

The system of claim 14, wherein the phenotype data interface comprises one or more of a phenotype data viewer, a query/visualization component, and a data exchange interface.

### Claim 16 (depends on 15)

The system of claim 15, wherein the query/visualization component is configured to query phenotype data stored in an acyclic graph.

### Claim 17 (depends on 14)

The system of claim 14, wherein the genetic variant data interface comprises one or more of a genetic variant data viewer, a query/visualization component, and/or a data exchange interface.

### Claim 18 (depends on 17)

The system of claim 17, wherein the query/visualization component is configured to query genetic variant data stored in one or more VCF files in the genetic data component.

### Claim 19 (depends on 18)

The system of claim 18, wherein the genetic data component is further configured to:
receive a plurality of VCF files;
determine one or more variant sites in common among the plurality of VCF files;
generate an index identifying presence or absence of the one or more variant sites for each of the plurality of VCF files;
encode a plurality of attributes as a single value for each of the plurality of VCF files; and
generate a final VCF file comprising the index and the encoded plurality of variables, wherein the query/visualization component is configured to query genetic variant data stored in the final VCF file.

### Claim 20 (depends on 17)

The system of claim 17, wherein the data exchange is configured to receive an output from the phenotype data interface, the pedigree interface, and the results interface to be used as input into the genetic variant data interface and to provide output of the genetic variant data interface to be used as input into the phenotype data interface, the pedigree interface, and the results interface.

### Claim 21 (depends on 14)

The system of claim 14, wherein the pedigree interface is configured to reconstruct a pedigree within a genetic dataset.

### Claim 22

A method, comprising:
receiving a plurality of variants from exome sequencing data;
assessing a functional impact of the plurality of variants;
generating an effect prediction element for each of the plurality of variants; and
assembling the effect prediction element into a searchable database comprising the plurality of variants.

### Claim 23

A method, comprising:
querying a genetic data component for a variant associated with a gene of interest;
passing the variant to a phenotypic data component as a query for a cohort possessing the variant;
passing the variant and the cohort to a genetic variant-phenotype association data component to determine an association result between the variant and a phenotype of the cohort;
passing the association result to a data analysis component to store and index the association result by at least one of the variant and the phenotype; and
querying the data analysis component by a target variant or a target phenotype, wherein the association result is provided in response.
